17 research outputs found
Final State Rescattering and Color-suppressed \bar B^0-> D^{(*)0} h^0 Decays
The color-suppressed \bar B^0-> D^{(*)0}\pi^0, D^{(*)0}\eta, D^0\omega decay
modes have just been observed for the first time. The rates are all larger than
expected, hinting at the presence of final state interactions. Considering \bar
B^0-> D^{(*)0}\pi^0 mode alone, an elastic D^{(*)}\pi -> D^{(*)}\pi
rescattering phase difference \delta \equiv \delta_{1/2} - \delta_{3/2} \sim
30^\circ would suffice, but the \bar B^0-> D^{(*)0}\eta, D^0\omega modes compel
one to extend the elastic formalism to SU(3) symmetry. We find that a universal
a_2/a_1=0.25 and two strong phase differences 20^\circ \sim \theta < \delta <
\delta^\prime \sim 50^\circ can describe both DP and D^*P modes rather well;
the large phase of order 50^\circ is needed to account for the strength of {\it
both} the D^{(*)0}\pi^0 and D^{(*)0}\eta modes. For DV modes, the nonet
symmetry reduces the number of physical phases to just one, giving better
predictive power. Two solutions are found. We predict the rates of the \bar
B^0-> D^{+}_s K^-, D^{*+}_s K^-, D^0\rho^0, D^+_s K^{*-} and D^0\phi modes, as
well as \bar B^0-> D^{0}\bar K^0, D^{*0}\bar K^0, D^{0}\bar K^{*0} modes. The
formalism may have implications for rates and CP asymmetries of charmless
modes.Comment: REVTeX4, 18 pages, 5 figures, to appear in Phys. Rev.
Primordial nucleosynthesis and hadronic decay of a massive particle with a relatively short lifetime
In this paper we consider the effects on big bang nucleosynthesis (BBN) of
the hadronic decay of a long-lived massive particle. If high-energy hadrons are
emitted near the BBN epoch ( -- ), they
extraordinarily inter-convert the background nucleons each other even after the
freeze-out time of the neutron to proton ratio. Then, produced light element
abundances are changed, and that may result in a significant discrepancy
between standard BBN and observations. Especially on the theoretical side, now
we can obtain a lot of experimental data of hadrons and simulate the hadronic
decay process executing the numerical code of the hadron fragmentation even in
the high energy region where we have no experimental data. Using the light
element abundances computed in the hadron-injection scenario, we derive a
constraint on properties of such a particle by comparing our theoretical
results with observations.Comment: 33 pages, 14 postscript figures, reference added, typo corrected, to
appear in Phys. Rev.
A study of the centrally produced pi0pi0pi0 channel in pp interactions at 450 GeV/c
The reaction pp -> pf (pi0pi0pi0) ps has been studied at 450 GeV/c. The
pi0pi0pi0 effective mass spectrum shows clear eta(547) and pi2(1670) signals.
Branching ratios for the eta(547) and pi_2(1670) are given as well as upper
limits for the decays of the omega(782), a1(1260) and a2(1320) into 3pi0.Comment: 10 pages, Latex, 4 Figure
Lattice Calculation of Heavy-Light Decay Constants with Two Flavors of Dynamical Quarks
We present results for , , , and their ratios in
the presence of two flavors of light sea quarks (). We use Wilson light
valence quarks and Wilson and static heavy valence quarks; the sea quarks are
simulated with staggered fermions. Additional quenched simulations with
nonperturbatively improved clover fermions allow us to improve our control of
the continuum extrapolation. For our central values the masses of the sea
quarks are not extrapolated to the physical , masses; that is, the
central values are "partially quenched." A calculation using "fat-link clover"
valence fermions is also discussed but is not included in our final results. We
find, for example,
MeV, , MeV, and , where in each case the first error is
statistical and the remaining three are systematic: the error within the
partially quenched approximation, the error due to the missing strange
sea quark and to partial quenching, and an estimate of the effects of chiral
logarithms at small quark mass. The last error, though quite significant in
decay constant ratios, appears to be smaller than has been recently suggested
by Kronfeld and Ryan, and Yamada. We emphasize, however, that as in other
lattice computations to date, the lattice quark masses are not very light
and chiral log effects may not be fully under control.Comment: Revised version includes an attempt to estimate the effects of chiral
logarithms at small quark mass; central values are unchanged but one more
systematic error has been added. Sections III E and V D are completely new;
some changes for clarity have also been made elsewhere. 82 pages; 32 figure
STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): An international consortium of randomised placebo-controlled trials
Background: Severe, early-onset fetal growth restriction due to placental insufficiency is associated with a high risk of perinatal mortality and morbidity with long-lasting sequelae. Placental insufficiency is the result of abnormal formation and function of the placenta with inadequate remodelling of the maternal spiral arteries. There is currently no effective therapy available. Some evidence suggests sildenafil citrate may improve uteroplacental blood flow, fetal growth, and meaningful infant outcomes. The objective of the Sildenafil TheRapy In Dismal prognosis Early onset fetal growth Restriction (STRIDER) collaboration is to evaluate the effectiveness of sildenafil versus placebo in achieving healthy perinatal survival through the conduct of randomised clinical trials and systematic review including individual patient data meta-analysis. Methods: Five national/bi-national multicentre randomised placebo-controlled trials have been launched. Women with a singleton pregnancy between 18 and 30 weeks with severe fetal growth restriction of likely placental origin, and where the likelihood of perinatal death/severe morbidity is estimated to be significant are included. Participants will receive either sildenafil 25 mg or matching placebo tablets orally three times daily from recruitment to 32 weeks gestation. Discussion: The STRIDER trials were conceived and designed through international collaboration. Although the individual trials have different primary outcomes for reasons of sample size and feasibility, all trials will collect a standard set of outcomes including survival without severe neonatal morbidity at time of hospital discharge. This is a summary of all the STRIDER trial protocols and provides an example of a prospectively planned international clinical research collaboration. All five individual trials will contribute to a pre-planned systematic review of the topic including individual patient data meta-analysis
Quantum dot superluminescent diodes for optical coherence tomography: device engineering
We present a 18 m W fiber-coupled single-mode super-luminescent diode with 85 nm bandwidth for application in optical coherence tomography (OCT). First, we describe the effect of quantum dot (QD) growth temperature on optical spectrum and gain, highlighting the need for the optimization of epitaxy for broadband applications. Then, by incorporating this improved material into a multicontact device, we show how bandwidth and power can be controlled. We then go on to show how the spectral shape influences the autocorrelation function, which exhibits a coherence length of < 11 mu m, and relative noise is found to be 10 dB lower than that of a thermal source. Finally, we apply the optimum device to OCT of in vivo skin and show the improvement that can be made with higher power, wider bandwidth, and lower noise, respectively
My Baby's Movements: a stepped-wedge cluster-randomised controlled trial of a fetal movement awareness intervention to reduce stillbirths
First published: 23 September 2021Objective: The My Babyâs Movements (MBM) trial aimed to evaluate the impact on stillbirth rates of a multifaceted awareness package (the MBM intervention). Design: Stepped-wedge cluster-randomised controlled trial. Setting: Twenty-seven maternity hospitals in Australia and New Zealand. Population: Women with a singleton pregnancy without major fetal anomaly at â„28âweeks of gestation from August 2016 to May 2019. Methods: The MBM intervention was implemented at randomly assigned time points, with the sequential introduction of eight groups of between three and five hospitals at 4-monthly intervals. Using generalised linear mixed models, the stillbirth rate was compared in the control and the intervention periods, adjusting for calendar time, study population characteristics and hospital effects. Main outcome measures: Stillbirth at â„28âweeks of gestation. Results: There were 304â850 births with 290â105 births meeting the inclusion criteria: 150â053 in the control and 140â052 in the intervention periods. The stillbirth rate was lower (although not statistically significantly so) during the intervention compared with the control period (2.2/1000 versus 2.4/1000 births; aORâ1.18, 95%âCI 0.93â1.50; Pâ=â0.18). The decrease in stillbirth rate was greater across calendar time: 2.7/1000 in the first versus 2.0/1000 in the last 18âmonths. No increase in secondary outcomes, including obstetric intervention or adverse neonatal outcome, was evident. Conclusions: The MBM intervention did not reduce stillbirths beyond the downward trend over time. As a result of low uptake, the role of the intervention remains unclear, although the downward trend across time suggests some benefit in lowering the stillbirth rate. In this study setting, an awareness of the importance of fetal movements may have reached pregnant women and clinicians prior to the implementation of the intervention.V Flenady, G Gardener, D Ellwood, M Coory, M Weller, KA Warrilow, PF Middleton, AM Wojcieszek, KM Groom, FM Boyle, C East, HLS Lawford, E Callander, JM Said, SP Walker, K Mahomed, C Andrews, A Gordon, JE Norman, C Crowthe